These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 33629796)
1. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression. Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796 [TBL] [Abstract][Full Text] [Related]
2. Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1. Tao S; Li H; Ma X; Ma Y; He J; Gao Y; Li J Cancer Gene Ther; 2021 Jun; 28(6):634-648. PubMed ID: 33154575 [TBL] [Abstract][Full Text] [Related]
3. Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis. Liu X; Jiang F; Wang Z; Tang L; Zou B; Xu P; Yu T J Cell Mol Med; 2021 Jan; 25(1):96-109. PubMed ID: 33219752 [TBL] [Abstract][Full Text] [Related]
4. LINC01915 Facilitates the Conversion of Normal Fibroblasts into Cancer-Associated Fibroblasts Induced by Colorectal Cancer-Derived Extracellular Vesicles through the miR-92a-3p/KLF4/CH25H Axis. Zhou M; Wang S; Liu D; Zhou J ACS Biomater Sci Eng; 2021 Nov; 7(11):5255-5268. PubMed ID: 34643375 [TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Extracellular Vesicles Promote Activation of Carcinoma-Associated Fibroblasts and Facilitate Invasion and Metastasis of Ovarian Cancer by Carrying miR-630. Cui Y; Wang D; Xie M Front Cell Dev Biol; 2021; 9():652322. PubMed ID: 34277601 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway. Wang S; Gao Y Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266 [TBL] [Abstract][Full Text] [Related]
7. Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression. Li C; Li R; Hu X; Zhou G; Jiang G Breast Cancer Res Treat; 2022 Apr; 192(2):353-368. PubMed ID: 35084622 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis. Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040 [TBL] [Abstract][Full Text] [Related]
9. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer. Ma ZH; Shi PD; Wan BS Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis. Wan X; Chen S; Fang Y; Zuo W; Cui J; Xie S J Cell Physiol; 2020 Nov; 235(11):8613-8625. PubMed ID: 32557673 [TBL] [Abstract][Full Text] [Related]
11. miR-4709-3p Inhibits Cell Proliferation by Downregulating Wang Y; Xu S; Wang S; Song Z; Zheng L; Wang G; Sun Y; Bao Y DNA Cell Biol; 2021 Jul; 40(7):969-978. PubMed ID: 33956530 [TBL] [Abstract][Full Text] [Related]
12. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
13. Hypoxic colorectal cancer-derived extracellular vesicles deliver microRNA-361-3p to facilitate cell proliferation by targeting TRAF3 via the noncanonical NF-κB pathways. Li J; Yang P; Chen F; Tan Y; Huang C; Shen H; Peng C; Feng Y; Sun Y Clin Transl Med; 2021 Mar; 11(3):e349. PubMed ID: 33784010 [TBL] [Abstract][Full Text] [Related]
14. Human bone marrow mesenchymal stem cell-derived extracellular vesicles impede the progression of cervical cancer via the miR-144-3p/CEP55 pathway. Meng Q; Zhang B; Zhang Y; Wang S; Zhu X J Cell Mol Med; 2021 Feb; 25(4):1867-1883. PubMed ID: 33417281 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516 [TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib. Zhang Y; Pan Q; Shao Z Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Yan Z; Sheng Z; Zheng Y; Feng R; Xiao Q; Shi L; Li H; Yin C; Luo H; Hao C; Wang W; Zhang B Cell Death Dis; 2021 Dec; 12(12):1120. PubMed ID: 34853307 [TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicle-Mediated miR-150-3p Delivery in Joint Homeostasis: A Potential Treatment for Osteoarthritis? Wang H; Shu J; Zhang C; Wang Y; Shi R; Yang F; Tang X Cells; 2022 Sep; 11(17):. PubMed ID: 36078172 [TBL] [Abstract][Full Text] [Related]
19. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559 [TBL] [Abstract][Full Text] [Related]
20. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway. Wang B; Mao JH; Wang BY; Wang LX; Wen HY; Xu LJ; Fu JX; Yang H Cancer Lett; 2020 Oct; 489():87-99. PubMed ID: 32531321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]